Literature DB >> 3586130

Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine.

K S Chen, D B Burlington, G V Quinnan.   

Abstract

Intragastric inoculation with whole-virion vaccine of inactivated influenza virus resulted in production of hemagglutinin (HA)-specific immunoglobulin A (IgA) and IgG both in lung lavage fluids and in serum samples of mice. HA-specific IgA was the predominant isotypic antibody secreted in the lung lavage fluids (average IgA/IgG ratio, 13:1), whereas HA-specific IgG was the major antibody class in serum (average IgA/IgG ratio, 0.3:1). These responses were similar to the antibody responses stimulated by intranasal infection with live influenza virus. In vitro cultures of lymphoid cells from lungs and Peyer's patches, but not from spleens, in the presence of homologous antigen, from mice vaccinated intragastrically synthesized mostly HA-specific IgA. Mice immunized parenterally with inactivated influenza virus produced only IgG in lung lavage fluids and sera. Cultures of lymphoid cells from their spleens, but not their lungs, synthesized HA-specific IgG upon antigenic stimulation in vitro; neither synthesized IgA. These in vitro cell culture results, as well as the inverse relationship of IgA/IgG ratios in lung lavage fluids and sera, demonstrated that the IgA antibody in lung lavage fluids was actively synthesized locally in the lungs of intragastrically immunized mice. This finding was consistent with the migratory distribution of antigen-primed lymphoid cells from Peyer's patches to distant lymphoid tissue such as lung. Intragastric vaccination conferred protection against intranasal challenge with a lethal dose of virulent virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3586130      PMCID: PMC254236     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Evaluation of monovalent influenza vaccines. II. Observations during an influenza a-prime epidemic.

Authors:  G MEIKLEJOHN; C H KEMPE; W G THALMAN; E H LENNETTE
Journal:  Am J Hyg       Date:  1952-01

2.  Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital.

Authors:  T W Hoskins; J R Davies; A J Smith; C L Miller; A Allchin
Journal:  Lancet       Date:  1979-01-06       Impact factor: 79.321

3.  Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system.

Authors:  P Weisz-Carrington; M E Roux; M McWilliams; J M PHILLIPS-Quagliata; M E Lamm
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

4.  Enteric immunization with live adenovirus type 21 vaccine. II. Systemic and local immune responses following immunization.

Authors:  R M Scott; B A Dudding; S V Romano; P K Russell
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

5.  Identification in a recombinant influenza virus of structural proteins derived from both parents.

Authors:  W G Laver; E D Kilbourne
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

6.  Effective immunity to dental caries: selective induction of secretory immunity by oral administration of Streptococcus mutans in rodents.

Authors:  S M Michalek; J R McGhee; R R Arnold; J Mestecky
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

7.  Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory.

Authors:  P F Wright; B R Murphy; M Kervina; E M Lawrence; M A Phelan; D T Karzon
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

8.  Testing the safety and effectiveness of oral administration of a live influenza vaccine.

Authors:  G I Aleksandrova; A A Smorodintsev; N M Beljaeva; B J Vasil'ev; R A Geft; V G Panteleev; M A Sejfer; A A Selivanov
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

9.  Antibodies against influenza and stimulated macrophages in the lung lavage fluid of mice following oral immunization.

Authors:  K C Bergmann; R H Waldman
Journal:  Allerg Immunol (Leipz)       Date:  1983

10.  Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis.

Authors:  R Ramphal; R C Cogliano; J W Shands; P A Small
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

View more
  13 in total

1.  The contribution of systemic and pulmonary immune effectors to vaccine-induced protection from H5N1 influenza virus infection.

Authors:  Yuk-Fai Lau; Amber R Wright; Kanta Subbarao
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

Review 2.  Mucosal vaccines for the prevention of influenza.

Authors:  R L Clancy
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

3.  Effects of haemorrhage on bacterial antigen specific pulmonary plasma cell function.

Authors:  A Robinson; E Abraham
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

4.  Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization models.

Authors:  L L Van De Verg; A B Hartman; A K Bhattacharjee; B D Tall; L Yuan; K Sasala; T L Hadfield; W D Zollinger; D L Hoover; R L Warren
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

5.  Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.

Authors:  R D Shahin; D F Amsbaugh; M F Leef
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

6.  Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection.

Authors:  C P Mallett; T L Hale; R W Kaminski; T Larsen; N Orr; D Cohen; G H Lowell
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

7.  A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunization.

Authors:  G T Pang; R L Clancy; S E O'Reilly; A W Cripps
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

8.  Oral immunization of rats with proteinoid microspheres encapsulating influenza virus antigens.

Authors:  N Santiago; S Milstein; T Rivera; E Garcia; T Zaidi; H Hong; D Bucher
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

9.  Oral and aerosol immunization with viable or inactivated Actinobacillus pleuropneumoniae bacteria: antibody response to capsular polysaccharides in bronchoalveolar lavage fluids (BALF) and sera of pigs.

Authors:  A Hensel; R Pabst; S Bunka; K Petzoldt
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

10.  Efficacy of oral administration of live herpes simplex virus type 1 as a vaccine.

Authors:  H Irie; Y Harada; M Kataoka; M Nagamuta; Y Moriya; M Handa; M Saito; S Matsubara; K Kojima; Y Sugawara
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.